Bio-Connect offers one of the most comprehensive portfolios of antibodies worldwide.
Innovative and high quality products focusing on advanced inflammation, immune response & immunometabolic research
AdipoGen Life Sciences, Inc. is a well-established manufacturer and worldwide distributor of innovative and high quality products focusing on advanced inflammation, immune response & immunometabolic research. Production is located in Switzerland, the US and Germany. A motivated team of highly-skilled individuals develops and manufactures new products for the life science research market. They focus their efforts on inflammation and immune response, including inflammasomes, innate immunity, B- and T-cells immune regulation, neuroinflammation, obesity, immuno-oncology and COVID-19 research. AdipoGen Life Sciences owns chemical laboratories, enabling the company to isolate unique natural products, to develop new and innovative small molecules, and to manufacture rare antibiotics.
Bio-Connect Life Sciences supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.
|Asc pAb (AL177) (AG-25B-0006)|
|Caspase-1 (p20) (mouse) mAb (Casper-1) (AG-20B-0042)|
|CD40L (human) (multimeric) (rec.) (AG-40B-0010)|
|IL-33 (oxidation resistant) (human) (rec.) (untagged) (AG-40B-0160)|
|Irisin Competitive ELISA Kit (AG-45A-0046Y)|
|Nampt (Visfatin/PBEF) (human) ELISA Kit (AG-45A-0006Y)|
|NLRP3/NALP3 mAb (Cryo-2) (AG-20B-0014)|
|Polyglutamylation Modification mAb (GT335) (AG-20B-0020)|
|Progranulin (human) ELISA Kit (AG-45A-0018Y)|
|VISTA (human):COMP (mouse) (rec.) (His) (AG-40B-0183)|
MultimericCD40L™ is a high activity construct in which two trimeric CD40 ligands are artificially linked via the collagen domain of ACRP30. This construct very effectively simulates the natural membrane-assisted aggregation of CD40L in vivo. It provides a simple and equally potent alternative to [CD40L+enhancer] combinations. MultimericCD40L™ has shown to suppress alum-induced IL-1β release and caspase-1 activation in a dose-, CD40- and time dependent manner, without affecting BMDM viability. It also effectively suppressed the inflammasome function triggered by NLRP3 activators. The secretion of caspase-1 independent inflammatory mediators has been shown to be unaltered or even enhanced.
Figure: CD40L (human) (multimeric) (rec.) (AG-40B-0010) does not need an enhancer to induce B cell activation.
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (AG-48B-0002)|
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, Alpha) (AG-48B-0003)|
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (P.1 Variant, Gamma) (AG-48B-0004)|
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, Beta) (AG-48B-0005)|
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, Kappa) (AG-48B-0006)|
|SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, Delta) (AG-48B-0007)|
We gladly support you by keeping you updated on our latest products and the developments around our services.